HAVN Life Sciences Inc. announced it has entered into a supply partnership with Atman Retreat, a retreat center helping people to explore psychedelics therapeutically, in order to harness the potential of healing, transformation, and transcendental experience. Pursuant to the Supply Partnership, HAVN Life will supply naturally derived psilocybin for use during Atman Retreat programs, which operate in compliance with local and international protocols. HAVN Life will provide Atman from its facility in Jamaica, where mushrooms are cultivated under GACP and processed in a GMP facility, with a product that ensures greater consistency and more accurate dosing, as well as better quality control compared to alternative local sources.

The first shipments to Atman are scheduled to be delivered in May 2022 to support retreats that are already scheduled.